Sign In
Buy ORMP
$4.07
-0.0500 (-1.21%)
At Close: Jul 31, 2026
Oramed Appoints Dr. Julio Rosenstock to Its Scientific Advisory Board
12:25pm, Thursday, 30'th Jan 2020
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced the addition
Oramed Patent in Europe to be Granted for Oral Delivery of Proteins
12:25pm, Tuesday, 28'th Jan 2020
Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) and (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the
Oramed Elects Dr. Alexander Fleming to Scientific Advisory Board
01:00pm, Thursday, 23'rd Jan 2020
NEW YORK, Jan. 23, 2020 Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, anno
Oramed Appoints Dr. Jay Skyler to Scientific Advisory Board
12:25pm, Tuesday, 21'st Jan 2020
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced the addition
Oramed Pharmaceuticals Issues Letter to Shareholders
12:00pm, Thursday, 09'th Jan 2020
Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, is pleased to provide the fo
